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Abstract: 
OBJECTIVE: To determine the frequency of dyslipidemia in diabetic and non diabetic population 
PATIENTS AND METHODS: This comparative cross sectional study of six months was conducted at tertiary care teaching 
hospital Hyderabad. The inclusion criteria of the study were diagnosed type-2 diabetic population, of ≥35 years of age, either 
gender and non diabetic healthy individual, of ≥35 years of age, either gender, not taking any lipid lowering therapy. The clinical 
history was taken and relevant investigations were performed by advising 12 hours over night fasting and the blood sample was 
taken on the next morning for the lipid profile. The data was collected on pre-designed proforma and analyzed in SPSS 16 
RESULTS: During six months study period, total fifty diabetic and fifty non diabetic individuals were evaluated for 
dyslipidemia. Out of 50 diabetic patients 35 males and 15 females and of 50 non diabetic individuals 30 males and 20 females 
respectively.  The dyslipidemia was observed in 43 type 2 diabetic patients, of which 27 were males and 16 were females. The 
dyslipidemia was observed in 21 healthy individuals of which 13 were males and 08 were females. The mean age ±SD for whole 
diabetic and non diabetic population was 52.97±8.95 and 49.97±7.53 while the mean ±SD for serum cholesterol, LDL, 
triglycerides and HDL in diabetic and non diabetic population was 230.76±5.83, 150.83±5.53, 320.82±7.95, 28.82±4.52 and 
160.98±8.54, 98.99±7.43, 189.75±8.82 and 37.86±5.96. The dyslipidemia was observed in 43 (86%) diabetic patients and 
22(44%) non diabetic individuals. 
CONCLUSION: Diabetic population is prone to be dyslipidemic as compared to non diabetics and predisposes them to 
premature ahterosclerosis and macrovascular complications 
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INTRODUCTION:  
Type-2 diabetes associated with insulin resistance 
occurs as a metabolic syndrome (also known as 
syndrome-X) in obese patients. Hypertension, 
dyslipidaemia and procoagulant state off addition to 
hyperglycaemia are it’s main features.[1-4] All 
cardiovascular risk factors except smoking are more 
prevalent in diabetics. Cigarette smoking appears to 
act synergistically with hypercholesterolaemia 
possibly by increasing the oxidation of LDL- 
cholesterol and elicits insulin resistance syndrome in 
diabetics who are chronic smokers. [5] Combination 
of raised triglycerides and low HDL-C constitutes the 
commonest pattern of dyslipidaemia in type-2 
diabetics. It’s features are high triglycerides, low 
HDL-C and qualitative change in LDL patients 
producing smaller but dense LDL-C particles, whose 
membranes carry supranormal amount of free 
cholesterol. A low HDL-C is a major risk factor 
predisposing to macrovascular disease. [6,7] 
Increased oxidized LDL-C found in diabetics 
provides a rationale for antioxident therapy. High 
plasma levels of vitamin-E reduce risk of coronary 
heart disease. Dietary antioxidants are strongly 
recommended in diabetics. [8] Current American 
Diabetes Association guidelines accord reducing 
LDL-C, the first treatment priority, followed by 
increasing HDL-C and lowering triglyceriders8. 
Statins are the first line agents for lowering LDL-C 
and after 4-6 weeks of treatment, statins reduce LDL 
and cholesterol. [9] Normalization of lipoprotein 
profile in diabetics has been demonstrated with good 
glycaemic control.[10] Therefore, this study was 
conducted to observe the dyslipidemia in diabetic and 
non diabetic population presented at tertiary care 
hospital Hyderabad. 
 
PATIENTS AND METHODS:  
This comparative cross sectional study of six months 
was conducted at tertiary care teaching hospital 
Hyderabad. The inclusion criteria of the study were 
diagnosed type-2 diabetic population, of ≥35 years of 
age, either gender and non diabetic healthy 
individual, of ≥35 years of age, either gender, not 
taking any lipid lowering therapy while the exclusion 
criteria were type-I Diabetic individuals, patients 
with history of acute myocardial infarction (up to six 
weeks), nephrotic syndrome, chronic liver disease, 
taking beta-blockers or thiazide diuretics or any lipid 
lowering regimen. Total one hundred subjects were 
recruited, fifty patients of type 2 diabetes mellitus 
and fifty healthy individuals. The informed consent 
was taken and both the groups were evaluated for 
their lipid profile to see the existence of dyslipidemia. 
The clinical history was taken and relevant 
investigations were performed by advising 12 hours 
over night fasting and the blood sample was taken on 
the next morning for the lipid profile. The data was 
collected on pre-designed proforma and analyzed in 
SPSS 16. The frequency and percentage was 
calculated while the mean ±SD was computed for 
numerical variables.     
 
RESULTS:  
During six months study period, total fifty diabetic 
and fifty non diabetic individuals were evaluated for 
dyslipidemia. Out of 50 diabetic patients 35 males 
and 15 females and of 50 non diabetic individuals 30 
males and 20 females respectively.  The dyslipidemia 
was observed in 43 type 2 diabetic patients, of which 
27 were males and 16 were females. The 
dyslipidemia was observed in 21 healthy individuals 
of which 13 were males and 08 were females. The 
mean age ±SD for whole diabetic and non diabetic 
population was 52.97±8.95 and 49.97±7.53 while the 
mean ±SD for serum cholesterol, LDL, triglycerides 
and HDL in diabetic and non diabetic population was 
230.76±5.83, 150.83±5.53, 320.82±7.95, 28.82±4.52 
and 160.98±8.54, 98.99±7.43, 189.75±8.82 and 
37.86±5.96. The results of the study are presented in 
Table 01 and 02. 
 
TABLE 01: THE AGE DISTRIBUTION OF DIABETIC AND NON DIABETIC POPULATION 
AGE (years) DIABETIC (N=50) NON – DIABETIC (N=50) 
35-39 08 (16%) 10 (20%) 
40-49 14 (28%) 15 (30%) 
50-59 18 (36%) 18 (36%) 
50+ 10 (20%) 07 (14%) 
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TABLE 02: THE FREQUENCY OF DYSLIPIDEMIA IN DIABETIC AND NON DIABETIC 
POPULATION 
DYSLIPIDEMIA TYPE-2 DIABETICS NON-DIABETICS 
SERUM TRIGLYCERIDES   
200-400 mg/dl 12 (27.9%) 06 (27.2%) 
>400 mg/dl 05 (11.6%) 03 (13.6%) 
   
SERUM CHOLESTEROL   
200-240mg/dl 08 (18.6%) 03 (13.6%) 
>240mg/dl 02 (4.6%) 02 (9%)  
   
SERUM LDL CHOLESTEROL   
100-159mg/dl 08 (18.6%) 02 (9%) 
>160mg/dl 01 (2.3%) 01 (4.5%) 
   
SERUM HDL CHOLESTEROL   
<35mg/dl 05 (11.6%) 03 (13.6%) 
   
MIXED DYSLIPIDEMIA 02 (4.6%) 01 (4.5%) 
   
TOTAL 43 22 
 
DISCUSSION:  
In present study, fasting lipid profile of one hundred 
individuals (fifty diabetic and fifty non diabetic) was 
assessed. The study conducted on dyslipidemia 
Associated with Poor Glycemic control in type 2 
Diabetes Mellitus shown that serum triglyceride was 
raised in 75% patients with controlled diabetes 
mellitus while in uncontrolled diabetes serum 
cholesterol was raised in 77% and serum triglycerides 
in 85% patients. [11] The findings of present study 
are also consistent. In present study, males had higher 
levels of LDL-C in comparison to females the finding 
is consistent with that of Ahmad MM, et al. [12] In 
current series, 11.6% diabetics had HDL-C 
<35mg/dl. Low HDL-C was a common associated 
finding with raised serum TG, serum cholesterol and 
LDL-C Framingham. [13] A former study conducted 
on diabetic population shown that serum cholesterol 
and LDL cholesterol were raised in 22% patients. 
[14] In our study serum cholesterol was raised in 
23% type-2 diabetics and LDL-C (>160mg/dl) was 
found in 20.9% diabetic patients. This finding was 
consistent with the former study. [14] The reason for 
difference is dietary habits between two populations. 
Hypertriglyceridaemia is the commonest lipid 
abnormality in type-2 diabetics, particularly those 
with uncontrolled diabetes and is a risk factor for 
macrovascular disorders due to reduced synthesis of 
hepatic insulin dependent lipoprotein lipase resulting 
in impaired clearance of IDL, chylomicrons and 
VLDL remnants. [16] Raised triglycerides are 
associated with decreased fibrinolysis and 
hypercoagulability contributing to coronary heart 
diseases. [17] In present study, serum TG was raised 
in 39.5% (the commonest dyslipidaemia seen among 
type-2 diabetics) and the findings is consistent with 
the study by Haider Z, et al. [14] Khan F, et al [18] 
observed hyperglyceridaemia the most prevalent lipid 
abnormality in diabetic population. In our study, 
raised serum TG was the commonest dyslipidaemia 
seen among type-2 diabetics. The study by Gulzar A, 
et al [19] shown 48% patients had 
hypercholesterolaemia, whereas another study shows 
hypercholesterolaemia in 30% patients. The reason 
for difference might be due to change in dietary 
habits of peoples.  Generally  it  is  known  that  good 
glycaemic  control leads  to  normalization  of  
dyslipidaemia , whereas  uncontrolled  diabetes  is  
usually  associated  with  marked  derangements  in  
lipid profile. [20] Another  important  component of 
the study was  evaluation of lipid profile in non 
diabetic individuals   because dyslipidaemia  in  non-
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diabetics  might  be  due to existence of underlying  
genetic  disorder, not known previously and in 
present study 22 (44%) patients healthy individuals 
founds to be dyslipidemic.  
Therefore diabetic dyslipidaemia  is long term  
complication  of  diabetes  mellitus  and  predisposes  
to  atherosclerotic  complications  occurring  in  the  
form  of  microangiopathy   or  macroangiopathy. 
Thus, early detection and management can reduce the 
mortality and morbidity. 
 
CONCLUSION:  
Diabetic population is prone to be dyslipidemic as 
compared to non diabetics and predisposes them to 
premature ahterosclerosis and macrovascular 
complications while the non diabetics population 
should also screened for existence of dyslipidemia. 
The good glycaemic control can prevent development 
and progression of lipid abnormalities among type 2 
diabetes mellitus. 
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